Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
11/27/2002 | CN1382041A Direct comperession polymer tablet core |
11/27/2002 | CN1382040A Therapeutic method |
11/27/2002 | CN1382039A Liposome formulation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5, 10-dione dimaleate |
11/27/2002 | CN1382038A New and improved formulation for paclitaxel |
11/27/2002 | CN1382037A Oral solution containing galanthamine and sweetening agent |
11/27/2002 | CN1382036A Solubilized pharmaceutical composition for parenteral administration |
11/27/2002 | CN1382034A Water-containing powder composition process for producing same and cosmetic preparation containing powder composition |
11/27/2002 | CN1381512A Multi-arm fork type functional polyethylene glycol preparation method and its application in medicine |
11/27/2002 | CN1094755C Controlled release agent containing reamine benzene ring alcohol or it salt |
11/26/2002 | US6486214 Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby |
11/26/2002 | US6486213 Block and graft copolymers and methods relating thereto |
11/26/2002 | US6486212 Semifluorinated alkanes and the use thereof |
11/26/2002 | US6486208 Sustained release, and comfortable opthalmic composition and method for ocular therapy |
11/26/2002 | US6486207 Compositions and methods for amelioration of human female sexual dysfunction |
11/26/2002 | US6486200 Prodrugs for antimicrobial amidines |
11/26/2002 | US6486182 Mutual prodrugs of amlodipine and atorvastatin |
11/26/2002 | US6486152 Topical carbamazepine formulations and methods of use |
11/26/2002 | US6486149 Dissolving crystalline cefditoren pivoxil substance and the water-soluble high-molecular additive in an aqueous solution of an acid, then neutralizing the resultant solution, to co-precipitate product, and drying |
11/26/2002 | US6486144 Method of treatment of liver tumors and pharmaceutical compositions for use therein |
11/26/2002 | US6486139 Ophthalmic solution comprising glycogen |
11/26/2002 | US6486138 Ophthalmic compositions containing galactomannan polymers and borate |
11/26/2002 | US6486124 Mixture of cyclosporin a and fatty ester |
11/26/2002 | US6486106 Composition |
11/26/2002 | US6485957 DNA encoding the human serine protease EOS |
11/26/2002 | US6485932 Composition comprising immunoglobulin |
11/26/2002 | US6485759 Botanical combinations for treating AIDS and immune-deficient patients to maintain good health and the process for preparing the same |
11/26/2002 | US6485757 Method of producing a liquid enriched with plant substances, liquid formed thereby, and products formed therefrom |
11/26/2002 | US6485755 Methods of using electron active compounds for managing cancer |
11/26/2002 | US6485747 Prepared by spraying the tablet with an aqueous composition comprising from about 0.5 wt % to about 3 wt % gellan gum |
11/26/2002 | US6485745 Dosage form exhibits accelerated release of the active agent |
11/26/2002 | US6485743 Dissolved itraconazole and hydrophilic polymer with solvent, spray-dried, and prepared into solid dispersion for oral preparation |
11/26/2002 | US6485742 Process for producing coated preparation and its use |
11/26/2002 | US6485741 Tablets, capsules |
11/26/2002 | US6485740 Transdermal methotrexate preparations |
11/26/2002 | US6485733 Absorbent article composition for sequestering skin irritants |
11/26/2002 | US6485726 Transepithelial delivery of antigens to provoke tolerance and immunity; the delivery of therapeutics conjugated to a fcrn binding partner to epithelium |
11/26/2002 | US6485718 Converting a polypeptide containing a serine as its n-terminal amino acid to an aldehyde; converting the amine of a synthetic particle to a oxiamine; and combining aldehyde polypeptide to oxiamine |
11/26/2002 | US6485707 Modulated release particles for aerosol delivery |
11/26/2002 | US6485706 Dehydration product of insulin and an orally effective nonsteroidal membrane-permeation enhancer, for administration to buccal mucosa via spraying suspension of solid particles |
11/26/2002 | US6485705 Dry pulverulent formulation comprising at least one film forming surfactant and a hydrophilic stabilizer in the presence of entrapable gas and an aqueous carrier phase mixable with said dry formulation |
11/26/2002 | US6485704 Azo compound for type I pototherapy |
11/26/2002 | CA2277017C Rapidly releasing and taste-masking pharmaceutical dosage form |
11/26/2002 | CA2094277C Processing of yeast refuse and resulting product |
11/26/2002 | CA2087164C Target specific antibody-superantigen conjugates and their preparation |
11/26/2002 | CA2076465C Cell binding agent conjugates of analogues and derivatives of cc-1065 |
11/26/2002 | CA2067184C New linker for bioactive agents |
11/21/2002 | WO2002092782A2 Diagnosis and treatment of malignant neoplasms |
11/21/2002 | WO2002092730A1 Process for the production of medicinal white oil using m41s and sulfur sorbent |
11/21/2002 | WO2002092667A1 Biodegradable polyphosphates for controlled release of bioactive substances |
11/21/2002 | WO2002092616A1 Antisense permeation enhancers |
11/21/2002 | WO2002092558A1 Polythiourea lipid derivatives |
11/21/2002 | WO2002092554A1 Complexes for transferring substances of interest into a cell |
11/21/2002 | WO2002092217A1 Vegetable protein-based microcapsules |
11/21/2002 | WO2002092136A2 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy |
11/21/2002 | WO2002092131A2 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins |
11/21/2002 | WO2002092130A1 Agent for improving tissue penetration |
11/21/2002 | WO2002092116A1 Targeted delivery of drugs for the treatment of viral infections |
11/21/2002 | WO2002092106A1 Taste masking pharmaceutical composition |
11/21/2002 | WO2002092092A1 Minoxidil-containing liquid composition |
11/21/2002 | WO2002092085A1 Pharmaceutical compositions comprising chelidonine or derivatives thereof |
11/21/2002 | WO2002092082A1 Stable high-concentration injection containing pyrazolone derivative |
11/21/2002 | WO2002092078A1 Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases |
11/21/2002 | WO2002092075A2 Therapeutic delivery of carbon monoxide |
11/21/2002 | WO2002092070A1 Isostearic acid salts as permeation enhancers |
11/21/2002 | WO2002092069A1 Permeation enhancers |
11/21/2002 | WO2002092061A1 Biorodible poly(orthoesters) from dioxolane-based diketene acetals |
11/21/2002 | WO2002092060A1 Abuse-resistant controlled-release opioid dosage form |
11/21/2002 | WO2002092059A1 Abuse-resistant opioid dosage form |
11/21/2002 | WO2002092056A1 Compaction process for manufacture of sodium phenytoin dosage form |
11/21/2002 | WO2002092055A1 Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
11/21/2002 | WO2002092054A2 Immune modulation device for use in animals |
11/21/2002 | WO2002092049A2 System for delivering cosmetics and pharmaceuticals |
11/21/2002 | WO2002092008A2 Use of il-18 inhibitors for the treatement or prevention of sepsis |
11/21/2002 | WO2002091996A2 Methods for treating cancer |
11/21/2002 | WO2002091992A2 Targeted delivery of drugs for the treatment of parasitic infections |
11/21/2002 | WO2002091991A2 Substantially homogeneous bio-affecting material having a pre-determined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use |
11/21/2002 | WO2002091989A2 Antiviral therapies using polyamine or polyamine analog-amino acid conjugates |
11/21/2002 | WO2002091966A1 Kavalactone compositions and methods of use |
11/21/2002 | WO2002091833A1 Prebiotic and probiotic compositions and methods for their use in gut-based therapies |
11/21/2002 | WO2002074310A3 Stabilized formulation of selective ligands of retinoic acid gamma-receptors |
11/21/2002 | WO2002072034A3 Chronotherapeutic dosage forms |
11/21/2002 | WO2002064148A3 Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders |
11/21/2002 | WO2002064108A3 Delivery of biologically active agents |
11/21/2002 | WO2002062318A3 Oral itraconazole formulations and methods of making the same |
11/21/2002 | WO2002058733A9 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
11/21/2002 | WO2002055720A3 Materials and methods relating to protein aggregation in neurodegenerative disease |
11/21/2002 | WO2002055089B1 Immunoassay technique using multispecific molecules |
11/21/2002 | WO2002043785A3 Intraocular implants for preventing transplant rejection in the eye |
11/21/2002 | WO2002043765A3 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof |
11/21/2002 | WO2002040536A3 Acylated antimicrobial peptides |
11/21/2002 | WO2002022169A3 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS |
11/21/2002 | WO2001034646A9 Recombinant gelatins |
11/21/2002 | US20020173851 Intervertebral disc treatment devices and methods |
11/21/2002 | US20020173736 Plaster containing 4-biphenylacetic acid |
11/21/2002 | US20020173669 Steroid hormone products and methods for preparing them |
11/21/2002 | US20020173643 Fusion protein delivery system and uses thereof |
11/21/2002 | US20020173586 Thermogelling biodegradable aqueous polymer solution |
11/21/2002 | US20020173552 Erodible polymers for injection |
11/21/2002 | US20020173547 Pharmaceuticals compositions |
11/21/2002 | US20020173516 Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye |